GILEAD SCIENCES INC Insider Trading for March 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in GILEAD SCIENCES INC for March 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 12,068 | |
| Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.35 | 2,413 | 181,820 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
| Mar 31 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
| Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 14,481 | |
| Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.27 | 2,413 | 181,627 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
| Mar 24 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
| Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 16,894 | |
| Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 67.26 | 2,413 | 162,298 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
| Mar 17 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 0.00 | 10,370 | 0 | 18,552 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | A | 72.34 | 61,590 | 4,455,421 | 61,590 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Option Exercise | M | 24.30 | 2,950 | 71,670 | 650 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 75.55 | 2,950 | 222,873 | 14,644 | 17.6 K to 14.6 K (-16.77 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Buy | M | 24.30 | 2,950 | 71,670 | 17,594 | 14.6 K to 17.6 K (+20.14 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 0.00 | 12,100 | 0 | 42,120 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Mercier Johanna | Chief Commercial Of ... | Option Exercise | A | 72.34 | 71,850 | 5,197,629 | 71,850 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 0.00 | 43,200 | 0 | 163,132 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | A | 72.34 | 256,620 | 18,563,891 | 256,620 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 0.00 | 12,100 | 0 | 41,116 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | A | 72.34 | 71,850 | 5,197,629 | 71,850 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Option Exercise | M | 0.00 | 769 | 0 | 29,016 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Payment of Exercise | F | 72.34 | 356 | 25,753 | 11,400 | 11.8 K to 11.4 K (-3.03 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Buy | M | 0.00 | 769 | 0 | 11,756 | 11 K to 11.8 K (+7.00 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Dickinson Andrew D | EVP, Chief Financia ... | Grant | A | 53.67 | 395 | 21,199 | 10,987 | 10.6 K to 11 K (+3.73 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 0.00 | 13,820 | 0 | 29,120 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Parsey Merdad | Chief Medical Offic ... | Option Exercise | A | 72.34 | 82,120 | 5,940,561 | 82,120 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 0.00 | 5,180 | 0 | 22,746 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | A | 72.34 | 17,630 | 1,275,354 | 17,630 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Option Exercise | M | 0.00 | 1,865 | 0 | 17,566 | |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Payment of Exercise | F | 72.34 | 524 | 37,906 | 12,199 | 12.7 K to 12.2 K (-4.12 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Buy | M | 0.00 | 1,865 | 0 | 12,723 | 10.9 K to 12.7 K (+17.18 %) |
| Mar 12 2020 | GILD | GILEAD SCIENCES IN ... | Wilfong Diane E. | SVP, Controller & C ... | Grant | A | 53.67 | 264 | 14,169 | 10,858 | 10.6 K to 10.9 K (+2.49 %) |
| Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 19.63 | 2,413 | 47,367 | 19,307 | |
| Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 77.97 | 2,413 | 188,142 | 54,860 | 57.3 K to 54.9 K (-4.21 %) |
| Mar 10 2020 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 19.63 | 2,413 | 47,367 | 57,273 | 54.9 K to 57.3 K (+4.40 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 42,925 | 0 | 119,932 | |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Option Exercise | M | 0.00 | 11,363 | 0 | 162,857 | |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Payment of Exercise | F | 69.36 | 25,922 | 1,797,950 | 47,570 | 73.5 K to 47.6 K (-35.27 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 42,925 | 0 | 73,492 | 30.6 K to 73.5 K (+140.43 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | O'Day Daniel Patrick | Chairman & CEO | Buy | M | 0.00 | 11,363 | 0 | 30,567 | 19.2 K to 30.6 K (+59.17 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 71.26 | 1,100 | 78,383 | 14,644 | 15.7 K to 14.6 K (-6.99 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Sell | S | 70.83 | 9,341 | 661,631 | 15,744 | 25.1 K to 15.7 K (-37.24 %) |
| Mar 03 2020 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP,Corp Affairs & ... | Grant | A | 53.67 | 395 | 21,199 | 25,085 | 24.7 K to 25.1 K (+1.60 %) |